文献速递甲状腺疾病

促甲状腺激素受体抗体:甲状腺眼病患者客观定量的炎症指标

Thyrotrophin Receptor Antibody: Objective and Quantitative Inflammatory Indicator in Patients With Thyroid Eye Disease.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

该研究纳入226例连续甲状腺眼病患者,分析促甲状腺激素受体抗体(TRAb)与临床活动度评分(CAS)的相关性,并在41例患者眶脂肪组织中检测27种炎症细胞因子,另在40例患者中评估静脉甲泼尼龙(IVMP)治疗后TRAb变化。结果显示TRAb与CAS相关性最强(r=0.427;P<.001),且与多种炎症因子相关,作者首次提出TRAb可能作为评估甲状腺眼病炎症的客观定量生物标志物。

要点

  • TRAb与CAS相关性最强(r=0.427;P<.001),并被确定为CAS最有影响力的因素。
  • TRAb与7种促炎细胞因子显著正相关,与1种抗炎细胞因子BMP-7显著负相关。
  • IVMP治疗后TRAb和CAS均显著下降,且两者下降程度显著相关。

核心结论

  • TRAb与临床炎症指标CAS及病理炎症标志物炎症细胞因子均显著相关,作者首次提出TRAb可能作为评估甲状腺眼病炎症的客观定量生物标志物。

研究设计与样本

  • 研究收集并分析了226例连续甲状腺眼病患者的TRAb及临床特征。
  • 另检测41例患者眶脂肪组织中27种炎症细胞因子,并评估40例患者IVMP治疗前后TRAb变化。

主要发现

  • 226例甲状腺眼病患者中女性116例、男性110例,平均年龄46.4±12.2岁。
  • TRAb与CAS相关性最强(r=0.427;P<.001),TRAb被确定为CAS最有影响力的因素。
  • TRAb与7种促炎细胞因子(IL-8、CCL-3、serpin E1、PDGF-AB、IL-12p70、IL-21、PDGF-BB)显著正相关,与1种抗炎细胞因子BMP-7显著负相关。
  • TRAb阳性患者眶脂肪组织中IL-8、CCL-3、serpin E1、PDGF-AB和IL-1β较TRAb阴性患者显著上调,BMP-7呈相反趋势。
  • IVMP治疗后TRAb和CAS均显著下降,且TRAb下降程度与CAS下降程度显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Accurate assessment of the inflammatory status in thyroid eye disease (TED) is crucial for diagnosis and treatment; however, this assessment remains challenging. OBJECTIVES: To study whether thyrotrophin receptor antibody (TRAb) can be utilized as a quantitative and objective indicator of the inflammatory status in patients with TED. METHODS: We gathered and analyzed TRAb and clinical characteristics from 226 consecutive TED patients. Additionally, we examined 27 inflammatory cytokines in the orbital adipose tissue of 41 patients and assessed the alterations in TRAb following IV methylprednisolone (IVMP) therapy in 40 patients. RESULTS: The 226 TED patients included 116 females and 110 males, with a mean age of 46.4 ± 12.2 years. The correlation between TRAb and clinical activity score (CAS) was the most pronounced (r = 0.427; P < .001). TRAb was identified as the most influential factor for CAS. Subsequent investigation into the relationship between TRAb and pathological inflammation revealed that TRAb exhibited a significant positive correlation with 7 proinflammatory cytokines [Interleukin (IL)-8, chemokine (C-C motif) ligand 3 (CCL-3), serpin E1, platelet-derived growth factor (PDGF)-AB, IL-12p70, IL-21, and PDGF-BB] and a significant negative correlation with 1 anti-inflammatory cytokine [bone morphogenetic protein 7 (BMP-7)]. IL-8, CCL-3, serpin E1, PDGF-AB, and IL-1β were significantly upregulated in the orbital adipose tissue of TRAb-positive patients compared to TRAb-negative patients. In contrast, BMP-7 demonstrated an opposite trend. Additionally, TRAb and CAS significantly decreased following IVMP therapy, with a significant correlation between the extent of reduction in TRAb and CAS. CONCLUSION: TRAb significantly correlated with both CAS (clinical inflammation indicator) and inflammatory cytokines (pathological inflammation marker). Consequently, we propose, for the first time, that TRAb may serve as an objective and quantitative biomarker for assessing inflammation in TED.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jing G, Tang J, Li Y, et al. Thyrotrophin Receptor Antibody: Objective and Quantitative Inflammatory Indicator in Patients With Thyroid Eye Disease. J Clin Endocrinol Metab. 2025. PMID: 40344181. doi:10.1210/clinem/dgaf273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。